Judy Mikovits

Judy A. Mikovits, PhD, was an ME/CFS researcher and previously the research director at the Whittemore Peterson Institute (WPI). Her research focus now centers mostly on autism.

She is one of the authors of the 2011 case definition, International Consensus Criteria.

XMRV
Dr Mikovits led the team that published a paper suggesting a connection between the XMRV retrovirus and ME/CFS. The XMRV paper was later retracted in 2011. Dr. Mikovits participated in a large study in 2012 that indicated that there was no association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus.

Arrest & lawsuit
Mikovits was fired from the WPI in 2011. After her departure there was a legal dispute, involving her arrest, with the WPI. Dr Mikovits' case against her critics was dismissed in February 2016.

Book - The Plague
In 2014 Dr Mikovits published a book called Plague about her experiences and research.

Talks and interviews

 * 2008, Speaker at the 3th Invest in ME International ME Conference; Speech title: How Sub Grouping will affect research strategies - (Video)
 * 2009, Speaker at the 4th Invest in ME International ME Conference on How Sub Grouping will affect research strategies
 * 2010, Speaker at the 5th Invest in ME International ME Conference on Implications of XMRV Research for ME/CFS DVD available
 * 04 Feb 2015, Spoonie Radio Episode 07 Guest - Dr. Judy Mikovits Part I - Podcast and Full Text Transcript
 * 01 Mar 2015, Spoonie Radio Episode 08 Guest - Dr. Judy Mikovits Part II - Podcast and Full Text Transcript
 * 22 Nov 2015, Interview with Dr. Judy Mikovits, PhD
 * 14 Dec 2015, Global Freedom Movement presents - Dr. Judy Mikovits Phd
 * 2011, Speaker at the 6th Invest in ME International ME Conference on Implications of XMRV Research for ME/CFS DVD available
 * 2016, Dr Judy Mikovits "We Are Carrying Potentially Deadly Retroviruses We Acquired Through Vaccination!"

Notable studies in ME/CFS

 * 2012, A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome (Full Text)

Learn more

 * Wikipedia - Judy Mikovits
 * 2009, XMRV explained on Nevada Newsmakers October 2009